Source:http://linkedlifedata.com/resource/pubmed/id/21237236
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
1-3
|
pubmed:dateCreated |
2011-2-14
|
pubmed:abstractText |
Carcinogenesis is often linked to aberrant activation of Wnt/?-catenin signalling, in many cases caused by activating CTNNB1 mutations (encoding ?-catenin). Recently, ?-catenin was established as a decisive regulator of hepatic glutamine synthetase (GS) and cytochrome P450 (CYP) expression in mouse hepatocarcinogenesis. This study was aimed to analyse the connection of ?-catenin signalling and GS/CYP expression in human paediatric tumours. Samples from 23 paediatric tumours were analysed for activating mutations in CTNNB1. Protein expression of the model ?-catenin target GS and of various CYP isoforms was analysed and correlated with CTNNB1 mutational status and histological findings. Activating CTNNB1 mutations were frequent in hepatoblastoma (80%) and nephroblastoma (31%). In CTNNB1-mutated hepatoblastoma, expression of GS was only detected in tumour areas with epithelial, not with mesenchymal differentiation. Particularly high expression of glutamine synthetase was found in hepatoblastoma cells directly neighbouring a mesenchymal-type tumour area or stroma cells, associated with above-average cell proliferation. GS expression was not observed in CTNNB1-mutated nephroblastoma. Hepatoblastoma with activated ?-catenin expressed different CYPs relevant for the metabolism of cytostatic drugs, but with high interindividual variance and heterogeneity within a single tumour. GS and different CYPs are co-expressed in hepatoblastoma with activated ?-catenin. Moreover, other factors like histological subtype of tumour cells and cell-cell-interactions at the borders between different areas of the tumours affect expression of these ?-catenin target genes. Analysis of CYP expression in resected tumour tissue might be useful for the selection of appropriate cytostatics for post-operative chemotherapy.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/CTNNB1 protein, human,
http://linkedlifedata.com/resource/pubmed/chemical/Cytochrome P-450 Enzyme System,
http://linkedlifedata.com/resource/pubmed/chemical/Glutamate-Ammonia Ligase,
http://linkedlifedata.com/resource/pubmed/chemical/Isoenzymes,
http://linkedlifedata.com/resource/pubmed/chemical/beta Catenin
|
pubmed:status |
MEDLINE
|
pubmed:month |
Mar
|
pubmed:issn |
1879-3185
|
pubmed:author | |
pubmed:copyrightInfo |
Copyright © 2011 Elsevier Ireland Ltd. All rights reserved.
|
pubmed:issnType |
Electronic
|
pubmed:day |
15
|
pubmed:volume |
281
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
7-14
|
pubmed:meshHeading |
pubmed-meshheading:21237236-Blotting, Western,
pubmed-meshheading:21237236-Cytochrome P-450 Enzyme System,
pubmed-meshheading:21237236-Gene Deletion,
pubmed-meshheading:21237236-Gene Expression Regulation, Neoplastic,
pubmed-meshheading:21237236-Glutamate-Ammonia Ligase,
pubmed-meshheading:21237236-Hepatoblastoma,
pubmed-meshheading:21237236-Humans,
pubmed-meshheading:21237236-Isoenzymes,
pubmed-meshheading:21237236-Liver Neoplasms,
pubmed-meshheading:21237236-Point Mutation,
pubmed-meshheading:21237236-beta Catenin
|
pubmed:year |
2011
|
pubmed:articleTitle |
Differential expression of glutamine synthetase and cytochrome P450 isoforms in human hepatoblastoma.
|
pubmed:affiliation |
Institute of Experimental and Clinical Pharmacology and Toxicology, Department of Toxicology, University of Tübingen, Wilhelmstr. 56, 72074 Tübingen, Germany.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|